Ledger.Open graph →
SEC Form D · Amendment · filed August 14, 2023

Skylark Bio, Inc

Offering
$34.9M
Sold
$22.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Will A. Mclean · Cambridge, MAExecGiampiero A. De Luca · Cambridge, MADirectorSteve A. Gillis · Cambridge, MADirectorJodi A. Cook · Cambridge, MAExec · DirectorPhineas Barnes · San Francisco, CADirectorDaniel Portillo · San Francisco, CADirectorWill A. Mclean · Cambridge, MAExecJodi A. Cook · Cambridge, MAExec · DirectorKip Mcclanahan · Austin, TXDirectorIgnace O. Van Waesberghe · New York, NYDirectorJared Birchall · Fremont, CAExec · DirectorBryan Baum · Miami Beach, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗